ZYLOX-TONBRDG.MED.TECH.H1 (F:818) — Market Cap & Net Worth
Market Cap & Net Worth: ZYLOX-TONBRDG.MED.TECH.H1 (818)
ZYLOX-TONBRDG.MED.TECH.H1 (F:818) has a market capitalization of $818.27 Million (€699.91 Million) as of May 5, 2026. Listed on the F stock exchange, this Germany-based company holds position #10042 globally and #1198 in its home market, demonstrating a 2.56% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ZYLOX-TONBRDG.MED.TECH.H1's stock price €2.40 by its total outstanding shares 320819113 (320.82 Million).
ZYLOX-TONBRDG.MED.TECH.H1 Market Cap History: 2021 to 2026
ZYLOX-TONBRDG.MED.TECH.H1's market capitalization history from 2021 to 2026. Data shows change from $960.18 Million to $900.17 Million (-16.68% CAGR).
ZYLOX-TONBRDG.MED.TECH.H1 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ZYLOX-TONBRDG.MED.TECH.H1's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 818 by Market Capitalization
Companies near ZYLOX-TONBRDG.MED.TECH.H1 in the global market cap rankings as of May 5, 2026.
Key companies related to ZYLOX-TONBRDG.MED.TECH.H1 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
ZYLOX-TONBRDG.MED.TECH.H1 Historical Marketcap From 2021 to 2026
Between 2021 and today, ZYLOX-TONBRDG.MED.TECH.H1's market cap moved from $960.18 Million to $ 900.17 Million, with a yearly change of -16.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €900.17 Million | +1.69% |
| 2025 | €885.17 Million | +81.54% |
| 2024 | €487.59 Million | -5.11% |
| 2023 | €513.85 Million | -6.80% |
| 2022 | €551.35 Million | -42.58% |
| 2021 | €960.18 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of ZYLOX-TONBRDG.MED.TECH.H1 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $818.27 Million USD |
| MoneyControl | $818.27 Million USD |
| MarketWatch | $818.27 Million USD |
| marketcap.company | $818.27 Million USD |
| Reuters | $818.27 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ZYLOX-TONBRDG.MED.TECH.H1
Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People's Republic of China and internationally. The company offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and in… Read more